FDA says single-dose shot from J&J prevents severe COVID

An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. |  Photo: Johnson & Johnson

LAURAN NEERGAARD and MATTHEW PERRONE
Updated: February 24, 2021 02:20 PM
Created: February 24, 2021 10:52 AM

WASHINGTON (AP) - An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19.

The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19.

On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot.

The FDA is expected to make a final decision within days.

If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.
 

Credits

LAURAN NEERGAARD and MATTHEW PERRONE

Copyright 2021 The Associated Press. All rights reserved.

Trial for former officer charged in Daunte Wright's death tentatively set for Dec. 6

Portion of Airport Road closed for a utility project

LSC hosts virtual commencement ceremony

Which major retailers have removed mask requirements?

City installing snow emergency route signs

Walz, legislative leaders reach $52 billion budget deal